JP2006506413A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006506413A5 JP2006506413A5 JP2004549603A JP2004549603A JP2006506413A5 JP 2006506413 A5 JP2006506413 A5 JP 2006506413A5 JP 2004549603 A JP2004549603 A JP 2004549603A JP 2004549603 A JP2004549603 A JP 2004549603A JP 2006506413 A5 JP2006506413 A5 JP 2006506413A5
- Authority
- JP
- Japan
- Prior art keywords
- agonist
- treating
- derivative
- chronic asthma
- separately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229940124748 beta 2 agonist Drugs 0.000 claims 9
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical class C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 claims 8
- 208000024716 acute asthma Diseases 0.000 claims 6
- 230000001154 acute effect Effects 0.000 claims 6
- 208000023819 chronic asthma Diseases 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 229940127212 long-acting beta 2 agonist Drugs 0.000 claims 2
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229960002848 formoterol Drugs 0.000 claims 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 claims 1
- 229960004017 salmeterol Drugs 0.000 claims 1
- QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 claims 1
- 229960001967 tacrolimus Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2002952559A AU2002952559A0 (en) | 2002-11-08 | 2002-11-08 | New use |
| PCT/JP2003/014077 WO2004041278A1 (en) | 2002-11-08 | 2003-11-04 | Use of tacrolimus (fk506) derivatives combined with beta2-agonists for the treatment of asthma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006506413A JP2006506413A (ja) | 2006-02-23 |
| JP2006506413A5 true JP2006506413A5 (enExample) | 2006-08-17 |
Family
ID=28795949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004549603A Withdrawn JP2006506413A (ja) | 2002-11-08 | 2003-11-04 | 喘息治療のためのタクロリムス（ＦＫ５０６）誘導体とβ２アゴニストとの併用使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20060035918A1 (enExample) |
| EP (1) | EP1558249A1 (enExample) |
| JP (1) | JP2006506413A (enExample) |
| KR (1) | KR20050071491A (enExample) |
| CN (1) | CN1691946A (enExample) |
| AU (1) | AU2002952559A0 (enExample) |
| CA (1) | CA2499719A1 (enExample) |
| WO (1) | WO2004041278A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1993564A4 (en) * | 2006-03-14 | 2010-05-26 | Wholesome Biopharma Pty Ltd | METHOD AND COMPOSITION FOR TREATING ALLERGIC DISEASES |
| CA2935801A1 (en) | 2014-01-13 | 2015-07-16 | Amplyx Pharmaceuticals, Inc. | Antifungal compounds |
| KR101632042B1 (ko) | 2014-06-30 | 2016-06-21 | 주식회사 인트론바이오테크놀로지 | Fk506 유도체를 함유하는 크립토코쿠스 속 곰팡이 및 칸디다 속 곰팡이에 의한 진균 감염을 치료하기 위한 약제학적 조성물 및 그의 용도 |
| KR102134782B1 (ko) * | 2018-12-11 | 2020-07-17 | 주식회사 인트론바이오테크놀로지 | 신규 화합물 및 이를 포함하는 신경계 질환 치료용 약학적 조성물 |
| CN113939519B (zh) * | 2018-12-11 | 2025-02-14 | 莫尔根生物有限公司 | 促进毛发生长的新化合物及包含它们的组合物 |
| WO2020122609A1 (ko) * | 2018-12-11 | 2020-06-18 | 주식회사 인트론바이오테크놀로지 | 신규 화합물 및 이를 포함하는 신경계 질환 치료용 약학적 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE64214B1 (en) * | 1989-06-06 | 1995-07-26 | Fujisawa Pharmaceutical Co | Macrolides for the treatment of reversible obstructive airways diseases |
| US5519049A (en) * | 1989-06-06 | 1996-05-21 | Fisons Plc | Macrolides for the treatment of reversible obstructive airways diseases |
| AU719613B2 (en) * | 1995-09-19 | 2000-05-11 | Astellas Pharma Inc. | Aerosol compositions |
| EP0918461B1 (en) * | 1996-07-29 | 2004-10-27 | Paringenix, Inc. | Methods of treating asthma with o-desulfated heparin |
-
2002
- 2002-11-08 AU AU2002952559A patent/AU2002952559A0/en not_active Abandoned
-
2003
- 2003-11-04 CN CNA2003801007188A patent/CN1691946A/zh active Pending
- 2003-11-04 EP EP03772677A patent/EP1558249A1/en not_active Withdrawn
- 2003-11-04 WO PCT/JP2003/014077 patent/WO2004041278A1/en not_active Ceased
- 2003-11-04 CA CA002499719A patent/CA2499719A1/en not_active Abandoned
- 2003-11-04 US US10/528,420 patent/US20060035918A1/en not_active Abandoned
- 2003-11-04 JP JP2004549603A patent/JP2006506413A/ja not_active Withdrawn
- 2003-11-04 KR KR1020057004238A patent/KR20050071491A/ko not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007514005A5 (enExample) | ||
| CL2007003444A1 (es) | Compuestos derivados de pirrolo[3,2-c]piridina; composicion farmaceutica; y uso en el tratamiento de un trastorno hiperproliferativo o una enfermedad inflamatoria. | |
| WO2007122580A3 (en) | Compositions of phenylephrine useful for treatment of respiratory illness | |
| JP2007513165A5 (enExample) | ||
| IL231576A (en) | Derivatives of adamantyl-acetamide, the pharmaceutical compositions containing them and their use in the preparation of medicines | |
| JP2009501177A5 (enExample) | ||
| JP2009501178A5 (enExample) | ||
| WO2006105401A3 (en) | Medicaments and methods combining an anticholinergic, a corticosteroid, and a long acting beta agonist | |
| JP2007523178A5 (enExample) | ||
| JP2004155791A5 (enExample) | ||
| JP2010285439A5 (enExample) | ||
| CL2007002526A1 (es) | Un medicamento que comprende, separado o juntos: a) una sal de glicopirronio; b) un agonista del adreno-receptor beta-2 seleccionado de salmeterol y formoterol; y c) un corticosteroide; kit farmaceutico; y uso en el tratamiento de una enfermedad infl | |
| WO2007082808A3 (en) | Thiazoles as 11 beta-hsd1 inhibitors | |
| WO2008062273A8 (en) | Solid oral dosage form having antidiabetic drug combination | |
| JP2008302206A5 (enExample) | ||
| JP2006526644A5 (enExample) | ||
| JP2005519891A5 (enExample) | ||
| JP2006514116A5 (enExample) | ||
| JP2008513510A5 (enExample) | ||
| CL2007002511A1 (es) | Compuestos derivados de pirrolo[2,3-f]isoquinolina, inhibidores de cinasa-2; proceso de preparacion; composicion farmaceutica; combinacion farmaceutica; y uso para el tratamiento de una enfermedad autoinmune. | |
| JP2006506413A5 (enExample) | ||
| AR058194A1 (es) | Medicamentos que comprenden un agente antimuscarinico y un corticoesteroide | |
| JP2008515980A5 (enExample) | ||
| JP2008513426A5 (enExample) | ||
| JP2009516719A5 (enExample) |